These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 239116)

  • 21. Effects of kainic acid on hypothermia induced by reserpine, oxotremorine and apomorphine in mice.
    Bourin M; Poisson L; Larousse C
    Arzneimittelforschung; 1987 Mar; 37(3):329-31. PubMed ID: 3593446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Possible mechanisms involved in the hyperthermic effect caused by reserpine after pretreatment with amphetamine or tranylcypromine in conscious rat.
    Cremades A; Jané F; Serrano JS; Milanés MV
    Methods Find Exp Clin Pharmacol; 1982; 4(8):569-73. PubMed ID: 7169844
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic L-DOPA treatment of mice: a behavioural and biochemical study.
    Bailey R; Crisp E; Jackson DM; Jenkins O
    J Neural Transm; 1981; 50(2-4):209-24. PubMed ID: 6787171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relative importance of dopamine and norepinephrine in mediating locomotor activity.
    Fishman RH; Feigenbaum JJ; Yanai J; Klawans HL
    Prog Neurobiol; 1983; 20(1-2):55-88. PubMed ID: 6141594
    [No Abstract]   [Full Text] [Related]  

  • 25. Is a dopaminergic system involved in thyrotropin releasing hormone induced hyperthermia and in its potentiation by amphetamine?
    Rips R; Desiles M; Puech AJ
    Prog Neuropsychopharmacol; 1979; 3(4):337-44. PubMed ID: 45568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on the mechanism of post-etorphine catalepsy. Modyfying effect of amphetamine, apomorphine and dihydroxy-phenylalanine (L-dopa) on etorphine-induced concentrations of dopamine and noradrenaline in the rat central nervous system.
    Kania BF
    Acta Physiol Pol; 1979; 30(2):279-87. PubMed ID: 572616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of dopaminergic stimulants on cyclic nucleotide levels in mouse brain in vivo.
    Gumulka SW; Dinnendahl V; Peters HD; Schönhöfer PS
    Naunyn Schmiedebergs Arch Pharmacol; 1976; 293(1):75-80. PubMed ID: 181689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monoamine replacement after reserpine: catecholaminergic agonists restore motor activity but phenylethylamine restores atropine-resistant neocortical low voltage fast activity.
    Vanderwolf CH; Robinson TE; Pappas BA
    Brain Res; 1980 Nov; 202(1):65-77. PubMed ID: 6968619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The role of the dopamine and noradrenaline systems in regulating autogenic motor activity in rat pups].
    Timofeeva OP
    Zh Evol Biokhim Fiziol; 1989; 25(1):123-5. PubMed ID: 2728686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological effects of 1,3-dimethyl-5-aminoadamantane, a new adamantane derivative.
    Maj J; Sowińska H; Baran L; Sarnek J
    Eur J Pharmacol; 1974 Apr; 26(1):9-14. PubMed ID: 4857604
    [No Abstract]   [Full Text] [Related]  

  • 31. Influence of dopaminergic agonists and antagonists on serum prolactin concentrations in the rat.
    Horowski R; Gräf HJ
    Neuroendocrinology; 1976; 22(3):273-86. PubMed ID: 1028957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. On certain effects of dopaminergic agents in pentylenetetrazol convulsions.
    Lazarova MB; Roussinov KS
    Acta Physiol Pharmacol Bulg; 1978; 4(3):50-5. PubMed ID: 751452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences in the cellular mechanism underlying the effects of amphetamine on prepulse inhibition in apomorphine-susceptible and apomorphine-unsusceptible rats.
    van der Elst MC; Wunderink YS; Ellenbroek BA; Cools AR
    Psychopharmacology (Berl); 2007 Jan; 190(1):93-102. PubMed ID: 17031706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antidepressant activities of WEB 1881, a new nootropic agent.
    Maj J; Rogóz Z; Skuza G; Sowińska H; Nowak G
    Pol J Pharmacol Pharm; 1989; 41(5):439-52. PubMed ID: 2561889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Catecholamines and self-stimulation: evidence suggesting a reinforcing role for noradrenaline and a motivating role for dopamine.
    Herberg LJ; Stephens DN; Franklin KB
    Pharmacol Biochem Behav; 1976 May; 4(5):575-82. PubMed ID: 133356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of central dopamine in the hyperthermia in rats produced by d-amphetamine.
    Ulus IH; Kiran BK; Ozkurt S
    Pharmacology; 1975; 13(4):309-16. PubMed ID: 1187755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of dopamine agonists and antagonists on DOPA formation in the substantia nigra.
    Argiolas A; Melis MR; Fadda F; Serra G; Gessa GL
    J Neurochem; 1982 Jan; 38(1):75-9. PubMed ID: 6809898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of tolerance in rats to the hypothermic effects of D-amphetamine and apomorphine.
    Chiel H; Yehuda S; Wurtman RJ
    Life Sci; 1974 Feb; 14(3):483-8. PubMed ID: 4150950
    [No Abstract]   [Full Text] [Related]  

  • 39. Differential effects of neuroleptic and serotonergic drugs on amphetamine-induced hypothermia in mice.
    Boschi G; Launay N
    Neuropharmacology; 1985 Feb; 24(2):117-22. PubMed ID: 2859540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The functional role of the noradrenergic neurons in the thermoregulatory circuits in mice.
    Schelkunov EL; Andreeva OG; Korovin KF; Ostroumova MN
    J Neural Transm; 1981; 50(2-4):113-37. PubMed ID: 6113267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.